Fierce BioTech

MAY 29, 2024

Top 5 Reasons for Futureproofing Cell Therapy Development Starting with high quality reagents is one good way to futureproof cell therapy programs. Download this whitepaper examine when and how to transition to GMP critical reagents.

Therapies 40

Therapies 40

Fierce BioTech

NOVEMBER 1, 2023

Plasmid DNA Design Considerations for Cell and Gene Therapy Cell and Gene therapy organizations must balance the need for rapid clinical progression and stringent quality expectations throughout development.

DNA 52

DNA Therapies RNA 52

Drug Channels

OCTOBER 28, 2022

Brooks introduces us to CareMetx’s specialty therapy warranty, a specialty patient outcome-based contract model. Download CareMetx’s 2022 Report: The Evolving Landscape of Digital Healthcare Hubs to learn more about digital hub services and CareMetx’s solutions that improve the patient journey.

Therapies 52

Therapies Production Drugs 52

Fierce BioTech

OCTOBER 19, 2023

How cell and gene therapies are forcing sponsors to rethink safety and efficacy monitoring In this whitepaper, we look at how the industry is rising to the challenge, focusing on how cell and gene therapies are radically improving health outcomes and the technologies and techniques that are facilitating their development. Download Now.

Therapies 52

Therapies Drug Development Treatment Research 52

Fierce BioTech

OCTOBER 22, 2024

Setting the Standard in CGT With unique perspectives from key opinion leaders, this whitepaper examines the challenges associated with process development and manufacturing of cell and gene therapies. Download this free guide to learn how we are setting the standard in cell and gene therapy, together.

Therapies 52

Therapies 52

The Pharma Data

MAY 16, 2021

Product Name: Audio Crystal Therapy One Time Offer. Click here to get Audio Crystal Therapy One Time Offer at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. Therapy Series ! Crystal Healing Music.

Therapies 52

Therapies Production Packaging Regulations 52

Fierce BioTech

JUNE 1, 2023

Download here! DCI cell therapy Puerto Rico cost-effectiveness Advanced Cell Technology Resource Type Whitepaper investpr logo.png Thu, 06/01/2023 - 10:21 Content Channel Diagnostics Devices Clinical Data Biotech Research Landing Page Url More Info Byline Sponsored by: Invest Puerto Rico

Therapies 52

Therapies Research 52

Fierce BioTech

JUNE 6, 2023

Accelerating the Development of Nucleic Acid Therapies at Harwell Science and Innovation Campus Harwell Campus offers rich opportunities for pioneering NAT technology on all fronts, and the campus is attracting biotechnology companies of all sizes – from Moderna to start-ups to Government research institutes and accelerators. Download here!

Science 52

Science Therapies Molecular Biology Government 52

Fierce BioTech

AUGUST 14, 2024

Download this brochure to delve into how IQVIA's expertise and innovative strategic approach can streamline the clinical trial process, helping to get new therapies to patients who need them sooner. Epilepsy Clinical Trials Finding an effective epilepsy treatment can be arduous.

Clinical Trials 52

Clinical Trials Trials Therapies Treatment 52

The Pharma Data

MAY 15, 2021

Product Name: The Neuro-Balance Therapy. Click here to get The Neuro-Balance Therapy at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. Plus instantly download the digital version and bonuses absolutely free.

Therapies 52

Therapies Production Vaccine 52

Fierce BioTech

SEPTEMBER 16, 2024

How next-generation phage display libraries are accelerating antibody developability Download now to learn how a next-generation phage library is overcoming the limitations of traditional antibody discovery platforms, enhancing the discovery of highly specific and effective antibody-based therapies.

Therapies 40

Therapies Drug Development Research Drugs 40

Drug Channels

MARCH 22, 2024

Adam discusses how patients seeking to access specialty therapies can benefit from a digital intake approach. To learn about AssistRx’s digital intake solutions, download Digital Intake for Specialty Drug Programs: Q1 2024 Progress Report.

Pharmaceutical Companies 87

Pharmaceutical Companies Therapies Pharmaceuticals Drugs 87

Fierce BioTech

MARCH 28, 2024

How Medical Affairs is Charting the Course for Pre- and Post-Launch Strategies Early involvement of Medical Affairs in advanced therapies is pivotal. Download to learn how Medical Affairs redefines healthcare and improves patient outcomes. Download to learn how Medical Affairs redefines healthcare and improves patient outcomes.

Biosimilars 52

Biosimilars Therapies Disease Drugs 52

Fierce BioTech

MAY 30, 2024

Quantify Cancer With Methylation-Based ctDNA Detection Download this resource to accelerate your oncology clinical trials, optimize patient enrollment, and monitor minimal residual disease and molecular response effectively.

Clinical Trials 52

Clinical Trials DNA Trials Therapies 52

Drug Channels

FEBRUARY 2, 2024

She highlights how GoodRx’s integrated pharma copay cards help to improve medication access, therapy adherence, and overall health outcomes. Click here to download the full report and learn more about partnering with GoodRx to drive patient access for your brand. Read on for Divya’s insights.

Therapies 79

Therapies Marketing Research Drugs 79

Drug Channels

SEPTEMBER 10, 2021

She argues that such a solution improves the provider experience, enhances the patient experience, and accelerates speed to therapy. To learn about CoverMyMeds’ integrated patient support services solution, download the free Medication Access Report: Healthcare Technology. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc.

Therapies 40

Therapies Production Drugs 40

The Pharma Data

OCTOBER 14, 2020

15, 2020 /PRNewswire/ — Thermo Fisher Scientific announced the launch of its Gibco CTS Rotea Counterflow Centrifugation System, a modular, closed cell therapy processing system that enables scalable, cost-effective cell therapy development and manufacturing. View original content to download multimedia: [link].

Therapies 52

Therapies Clinical Trials Science Laboratories 52

Drug Channels

SEPTEMBER 8, 2023

Nasir discusses how hubs help patients initiate and adhere to drug therapies. Learn more by downloading CareMetx’s full report: The Evolving Landscape of Digital Healthcare Hubs. Today’s guest post comes from Nasir Ali, Chief Product Officer at CareMetx. Read on for Nasir’s insights.

Pharmaceuticals 74

Pharmaceuticals Therapies Production Drugs 74

Drug Channels

AUGUST 11, 2023

Today’s guest post comes from Rebecca Cotton, Executive Director of Strategy & Product Innovation at Cardinal Health ™ Sonexus ™ Access and Patient Support Rebecca discusses the essential features biopharmaceutical manufacturers should seek in a digital hub that will help patients get their therapies faster.

Therapies 66

Therapies Production Drugs 66

Drug Channels

AUGUST 18, 2023

Divya discusses the challenges patients face in accessing specialty therapies prescribed by their healthcare providers. Learn more about GoodRx’s insights and solutions for specialty treatments by downloading their free yellow paper: Access and Affordability Insights: Differences Across Specialties.

Treatment 77

Treatment Therapies Drugs 77

Drug Channels

MARCH 3, 2023

Jan discusses digital hubs and the benefits they offer both patients on specialty therapies and their health care providers. To learn more, download AssistRx's free 61-page eBook: Specialty Drug Patient Support Programs: 2022 Progress Report. Read on for Jan’s insights. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Therapies 75

Therapies Drugs 75

The Pharma Data

NOVEMBER 1, 2020

Corlieve’s lead program employs a novel AAV gene therapy approach for the treatment of refractory temporal lobe epilepsy (TLE), the most commonly diagnosed focal epilepsy in humans. Maryland , US), a leading gene therapy company. Maryland , US), a leading gene therapy company. PARIS , Nov.

Therapies 52

Therapies Science Treatment Disease 52

Drug Channels

MARCH 10, 2023

Stacey discusses digital hubs and the affordability advantages they offer both patients on specialty therapies and their health care providers. Download AssistRx's free 61-page eBook here: Specialty Drug Patient Support Programs: 2022 Progress Report.

Specialty Pharmacies 79

Specialty Pharmacies Pharmacy Therapies Marketing 79

Fierce BioTech

NOVEMBER 16, 2023

Beyond cfDNA: Harnessing the Power of Exosomes to Improve Sensitivity for Cancer Mutation Detection Liquid biopsy markers are advantageous because they can be used to assess overall prognosis, response to therapy, and likelihood of relapse or progression. Download now.

RNA 52

RNA DNA Therapies Treatment 52

Fierce BioTech

JULY 25, 2023

How combining datasets from multiple sources can inform and improve commercial strategies Hundreds of rare disease treatments have entered the market over the past decade—thanks largely to a combination of government incentives, strong urging from patient advocacy groups and advances in cell and gene therapies.

Pharma Companies 52

Pharma Companies Government Therapies Disease 52

Drug Channels

FEBRUARY 11, 2022

He describes patient-centric, data-driven solutions to help patients access, afford, and adhere to their therapies. To learn more, download CoverMyMeds’ 2022 Medication Access Report. John discusses some of the findings in CoverMyMeds’ recently published report on medication access. Read on for John’s insights.

Therapies 87

Therapies Drugs 87

DrugBank

AUGUST 20, 2024

You’ll discover real-world examples, such as the transformation of KRAS from an undruggable target to a success story in targeted therapy. We provide insights into how you can improve efficiency, success rates, and ultimately bring more effective therapies to market.

Therapies 72

Therapies Pharmaceuticals Disease Research 72

Fierce BioTech

JULY 28, 2023

Download here! jsabatino Fri, 07/28/2023 - 11:29 In this white paper, we look at the past, present and future of antibodies as therapies, explaining how the modality became a key pillar of the biopharma industry—and looking forward to the methods and technologies that could unleash its full potential in the years to come.

Therapies 52

Therapies Drug Development Research Drugs 52

Drug Channels

APRIL 23, 2021

Erica discusses four technology areas that the healthcare network can embrace to increase speed to therapy, affordability, and adherence. To learn more about CoverMyMeds’ technology solutions, download their new whitepaper: Helping Patients Access Specialty Therapies: Autoimmune Conditions. Free download ).

Therapies 52

Therapies Drugs 52

The Pharma Data

JANUARY 27, 2021

HK), announced today that China Center for Drug Evaluation (CDE) has granted Breakthrough Therapy designation to Batoclimab (HBM 9161), a fully human anti-FcRn monoclonal antibody (mAb), for the treatment of adult patients with Myasthenia Gravis (MG). View original content to download multimedia: [link]. CAMBRIDGE, Mass.

Therapies 52

Therapies Treatment International Licensing 52

Fierce BioTech

NOVEMBER 28, 2023

Explore how suspension cells lead the way, providing a robust and adaptable manufacturing platform for gene therapy breakthroughs. Explore how suspension cells lead the way, providing a robust and adaptable manufacturing platform for gene therapy breakthroughs. Download now.

Therapies 40

Therapies Production Drugs 40

The Pharma Data

NOVEMBER 23, 2020

CMTI) has received 60+ red light therapy (RLT) modules for initial photonics testing and product fabrication. View original content to download multimedia: [link]. FRISCO, Texas , Nov. 24, 2020 /PRNewswire/ — Curtis Mathes Corporation (OTC: TLED) subsidiary, Curtis Mathes Therapeutics, Inc.

Therapies 52

Therapies Treatment Production Research 52

PPD

NOVEMBER 4, 2024

Increasing complexity of clinical trials rounds out the list of the top challenges facing sponsors in 2024, driven by factors such as enrollment of hard-to-find patient populations , compliance with complex regulatory requirements and innovative therapies that require complex protocols.

Drug Development 52

Drug Development Clinical Trials Clinical Research Trials 52

Drug Target Review

JUNE 13, 2023

Don’t miss your chance to embrace the future of cellular therapies – dive in now! Download your FREE copy today. Immerse yourself in exclusive content, including articles on cutting-edge cell line development and insightful interviews with industry experts. This eBook is supported by BioTechne.

Engineering 52

Engineering Pharmacy Drug Development Therapies 52

Drug Channels

FEBRUARY 6, 2024

Just choose your preferred event and prepare to walk away inspired and armed with the knowledge necessary to drive patient access forward. Which event is for you?

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Pharma Companies Disease 40

The Pharma Data

DECEMBER 22, 2020

Primary endpoints of this study include safety, tolerability, and tumor response of the ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy. Outside of Japan , Illuminox therapies have not yet been approved as safe or effective by any regulatory authority. SAN MATEO, Calif. , ” About Rakuten Medical, Inc.

Clinical Trials 52

Clinical Trials Therapies Trials Production 52

The Pharma Data

SEPTEMBER 17, 2020

17, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE:LLY) and Amgen (NASDAQ:AMGN) today announced a global antibody manufacturing collaboration to significantly increase the supply capacity available for Lilly ‘s potential COVID-19 therapies. View original content to download multimedia: [link]. SOURCE Eli Lilly and Company.

Therapies 52

Therapies Production Government Disease 52